Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses

被引:26
作者
Kida, E [1 ]
Golabek, AA [1 ]
Wisniewski, KE [1 ]
机构
[1] New York State Inst Basic Res Dev Disabil, Dept Pathol Neurobiol, Staten Isl, NY 10314 USA
来源
BATTEN DISEASE: DIAGNOSIS, TREATMENT, AND RESEARCH | 2001年 / 45卷
关键词
D O I
10.1016/S0065-2660(01)45003-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lysosomal accumulation of autofluorescent, ceroid lipopigment material in various tissues and organs is a common feature of the neuronal ceroid lipofuscinoses (NCLs). However, recent clinicopathologic and genetic studies have evidenced that NCLs encompass a group of highly heterogeneous disorders. In five of the eight NCL variants distinguished at present, genes associated with the disease process have been isolated and characterized (CLN1, CLN2, CLN3, CLN5, CLN8). Only products of two of these genes, CLN1 and CLN2, have structural and functional properties of lysosomal enzymes. Nevertheless, according to the nature of the material accumulated in the lysosomes, NCLs in humans as well as natural animal models of these disorders can be divided into two major groups: those characterized by the prominent storage of saposins A and D, and those showing the predominance of subunit c of mitochondrial ATP synthase accumulation. Thus, taking into account the chemical character of the major component of the storage material, NCLs can be classified currently as preoteinoses. Of importance, although lysosomal storage material accumulates in NCL subjects in various organs, only brain tissue shows severe dysfunction and cell death, another common feature of the NCL disease process. However, the relation between the genetic defects associated with the NCL forms, the accumulation of storage material, and tissue damage is still unknown. This chapter introduces the reader to the complex pathogenesis of NCLs and summarizes our current knowledge of the potential consequences of the genetic defects of NCL-associated proteins on the biology of the cell. © 2001.
引用
收藏
页码:35 / 68
页数:34
相关论文
共 153 条
[1]   EVIDENCE FOR LIPASE ABNORMALITY - HIGH-LEVELS OF FREE AND TRIACYLGLYCEROL FORMS OF UNSATURATED FATTY-ACIDS IN NEURONAL CEROID-LIPOFUSCINOSIS TISSUE [J].
BANERJEE, P ;
DASGUPTA, A ;
SIAKOTOS, AN ;
DAWSON, G .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 42 (04) :549-554
[2]   Inhibition of cellular processing of surfactant protein C by drugs affecting intracellular pH gradients [J].
Beers, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14361-14370
[3]   KUFS DISEASE - A CRITICAL REAPPRAISAL [J].
BERKOVIC, SF ;
CARPENTER, S ;
ANDERMANN, F ;
ANDERMANN, E ;
WOLFE, LS .
BRAIN, 1988, 111 :27-62
[4]   The mechanism and functional roles of protein palmitoylation in the nervous system [J].
Bizzozero, OA .
NEUROPEDIATRICS, 1997, 28 (01) :23-26
[5]   PIGMENTOARCHITECTONIC PATHOLOGY OF THE ISOCORTEX IN JUVENILE NEURONAL CEROID-LIPOFUSCINOSIS - AXONAL ENLARGEMENTS IN LAYER-IIIAB AND CELL LOSS IN LAYER-V [J].
BRAAK, H ;
GOEBEL, HH .
ACTA NEUROPATHOLOGICA, 1979, 46 (1-2) :79-83
[6]  
BRAULKE T, 1987, EUR J CELL BIOL, V43, P316
[7]   Ovine neuronal ceroid lipofuscinosis: a large animal model syntenic with the human neuronal ceroid lipofuscinosis variant CLN6 [J].
Broom, MF ;
Zhou, CM ;
Broom, JE ;
Barwell, KJ ;
Jolly, RD ;
Hill, DF .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (09) :717-721
[8]  
BRUCK W, 1998, CLIN NEUROPATHOL, V5, P276
[9]  
BUTOR C, 1995, J CELL SCI, V108, P2213
[10]  
Buzy A, 1996, RAPID COMMUN MASS SP, V10, P790